BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Somvanshi RK, Kumar U. δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling. PLoS One 2014;9:e85193. [PMID: 24416361 DOI: 10.1371/journal.pone.0085193] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Somvanshi RK, Jhajj A, Heer M, Kumar U. Characterization of somatostatin receptors and associated signaling pathways in pancreas of R6/2 transgenic mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:359-73. [DOI: 10.1016/j.bbadis.2017.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Park TSW, Khan N, Kuo A, Nicholson JR, Corradini L, Smith MT. J-2156, a somatostatin receptor type 4 agonist, alleviates mechanical hyperalgesia in a rat model of chronic low back pain. Biomed Pharmacother 2019;117:109056. [PMID: 31181441 DOI: 10.1016/j.biopha.2019.109056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mika J, Popiolek-Barczyk K, Rojewska E, Makuch W, Starowicz K, Przewlocka B. Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain. PLoS One 2014;9:e104420. [PMID: 25105291 DOI: 10.1371/journal.pone.0104420] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
4 Abdel-Magid AF. Treating pain with somatostatin receptor subtype 4 agonists. ACS Med Chem Lett 2015;6:110-1. [PMID: 25699156 DOI: 10.1021/ml500538a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Singh S, Somvanshi RK, Panda V, Kumar U. Comparative distribution of somatostatin and somatostatin receptors in PTU-induced hypothyroidism. Endocrine 2020;70:92-106. [PMID: 32335798 DOI: 10.1007/s12020-020-02309-1] [Reference Citation Analysis]
6 Ibáñez-Costa A, Korbonits M. AIP and the somatostatin system in pituitary tumours. J Endocrinol 2017;235:R101-16. [PMID: 28835453 DOI: 10.1530/JOE-17-0254] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
7 Bodnar RJ. Endogenous opiates and behavior: 2014. Peptides 2016;75:18-70. [PMID: 26551874 DOI: 10.1016/j.peptides.2015.10.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
8 Schuelert N, Just S, Kuelzer R, Corradini L, Gorham LC, Doods H. The somatostatin receptor 4 agonist J-2156 reduces mechanosensitivity of peripheral nerve afferents and spinal neurons in an inflammatory pain model. Eur J Pharmacol 2015;746:274-81. [PMID: 25445035 DOI: 10.1016/j.ejphar.2014.11.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
9 Root-Bernstein R, Churchill B. Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities. Life (Basel) 2021;11:1217. [PMID: 34833093 DOI: 10.3390/life11111217] [Reference Citation Analysis]
10 Solarski M, Williams D, Mehrabian M, Wang H, Wille H, Schmitt-Ulms G. The human brain somatostatin interactome: SST binds selectively to P-type family ATPases. PLoS One 2019;14:e0217392. [PMID: 31136617 DOI: 10.1371/journal.pone.0217392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Zou S, Somvanshi RK, Paik S, Kumar U. Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus. J Mol Neurosci 2015;55:480-91. [PMID: 25001005 DOI: 10.1007/s12031-014-0369-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
12 Mariotti L, Losi G, Lia A, Melone M, Chiavegato A, Gómez-Gonzalo M, Sessolo M, Bovetti S, Forli A, Zonta M, Requie LM, Marcon I, Pugliese A, Viollet C, Bettler B, Fellin T, Conti F, Carmignoto G. Interneuron-specific signaling evokes distinctive somatostatin-mediated responses in adult cortical astrocytes. Nat Commun 2018;9:82. [PMID: 29311610 DOI: 10.1038/s41467-017-02642-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
13 Kántás B, Börzsei R, Szőke É, Bánhegyi P, Horváth Á, Hunyady Á, Borbély É, Hetényi C, Pintér E, Helyes Z. Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain. Int J Mol Sci 2019;20:E6245. [PMID: 31835716 DOI: 10.3390/ijms20246245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
14 Dasgupta P, Gűnther T, Schulz S. Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist. Life (Basel) 2021;11:1075. [PMID: 34685446 DOI: 10.3390/life11101075] [Reference Citation Analysis]
15 Park TSW, Khan N, Kuo A, Nicholson JR, Corradini L, Smith MT. Characterisation of a rat model of mechanical low back pain at an advanced stage using immunohistochemical methods. Clin Exp Pharmacol Physiol 2020. [PMID: 32888350 DOI: 10.1111/1440-1681.13402] [Reference Citation Analysis]
16 Gendron L, Cahill CM, von Zastrow M, Schiller PW, Pineyro G. Molecular Pharmacology of δ-Opioid Receptors. Pharmacol Rev 2016;68:631-700. [PMID: 27343248 DOI: 10.1124/pr.114.008979] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
17 Kumar U, Heer M, Somvanshi RK. Regional and subcellular distribution of GABAC ρ3 receptor in brain of R6/2 mouse model of Huntington's disease. Neurosci Lett 2017;640:81-7. [PMID: 28104430 DOI: 10.1016/j.neulet.2017.01.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Shenoy PA, Kuo A, Khan N, Gorham L, Nicholson JR, Corradini L, Vetter I, Smith MT. The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain. Front Pharmacol 2018;9:495. [PMID: 29867498 DOI: 10.3389/fphar.2018.00495] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Pozsgai G, Payrits M, Sághy É, Sebestyén-Bátai R, Steen E, Szőke É, Sándor Z, Solymár M, Garami A, Orvos P, Tálosi L, Helyes Z, Pintér E. Analgesic effect of dimethyl trisulfide in mice is mediated by TRPA1 and sst4 receptors. Nitric Oxide 2017;65:10-21. [PMID: 28137611 DOI: 10.1016/j.niox.2017.01.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]